Number of employees
50
Annual revenue
$4100000
Xcellerex offers contract services for bioprocess development and manufacturing. Process development services include the full range of process optimization activities using the PDMax™ platform. Manufacturing services include microbial manufacturing under cGMP and mammalian manufacturing using the proprietary FlexFactory™ platform. Xcellerex can provide assistance with management of GMP cell banking, management of cell line testing and assistance with preparation of documentation for IND or other regulatory filings.